Request for Covid-19 Impact Assessment of this Report
Geographically, the global Oncology Biosimilar market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.
North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total Oncology Biosimilar market in North America.
Significant participants active in the global Oncology Biosimilar market include: Hospira, Baxter, Mylan, Celltrion, BioXpress Therapeutics, Dr. Reddy's Laboratories, F. Hoffmann-La Roche, AbbVie, Boehringer Ingelheim, Biogen, Biocon, Allergan, AstraZeneca, Sandoz, Amgen...
Global Oncology Biosimilar Market Segmentation:
Oncology Biosimilar market, by Oncology Biosimilar type:
Protein
Hormones
Uucleic Acids
…
Oncology Biosimilar market, by Application:
Application 1
Application 2
Application 3
…
Oncology Biosimilar Market Research Report 2014-2026, by region:
North America
The U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Pan Asia Pacific
China
Japan
South Korea
South East Asia Region
India
Australia
Middle East and Africa
Saudi Arabia
UAE
Qatar
Egypt
Nigeria
South Africa
Rest of MEA
The database is running updated by a group of research experts to always reflect the latest trends and information.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Oncology Biosimilar by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Oncology Biosimilar Market-Segmentation
4.1 By Type
4.1.1 Protein
4.1.2 Hormones
4.1.3 Uucleic Acids
4.2 By End-User/Application Industry
4.2.1 Application 1
4.2.2 Application 2
4.2.3 Application 3
4.3 By Geography
4.3.1 North America Oncology Biosimilar Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Oncology Biosimilar Production from 2014-2020
4.3.1.2 North America Oncology Biosimilar Consumption from 2014-2020
4.3.1.3 North America Oncology Biosimilar Import and Export from 2014-2020
4.3.1.4 North America Oncology Biosimilar Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Oncology Biosimilar Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Oncology Biosimilar Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Oncology Biosimilar Participants Value ($) and Market Share (%) in 2019
4.3.2 Europe Oncology Biosimilar Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Oncology Biosimilar Production from 2014-2020
4.3.2.2 Europe Oncology Biosimilar Consumption from 2014-2020
4.3.2.3 Europe Oncology Biosimilar Import and Export from 2014-2020
4.3.2.4 Europe Oncology Biosimilar Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Oncology Biosimilar Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Oncology Biosimilar Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Oncology Biosimilar Participants Value ($) and Market Share (%) in 2019
4.3.3 Asia-Pacific Oncology Biosimilar Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Oncology Biosimilar Production from 2014-2020
4.3.3.2 Asia-Pacific Oncology Biosimilar Consumption from 2014-2020
4.3.3.3 Asia-Pacific Oncology Biosimilar Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Oncology Biosimilar Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Oncology Biosimilar Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Oncology Biosimilar Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Oncology Biosimilar Participants Value ($) and Market Share (%) in 2019
4.3.4 Latin America Oncology Biosimilar Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Oncology Biosimilar Production from 2014-2020
4.3.4.2 Latin America Oncology Biosimilar Consumption from 2014-2020
4.3.4.3 Latin America Oncology Biosimilar Import and Export from 2014-2020
4.3.4.4 Latin America Oncology Biosimilar Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Oncology Biosimilar Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Oncology Biosimilar Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Oncology Biosimilar Participants Value ($) and Market Share (%) in 2019
4.3.5 Middle East & Africa Oncology Biosimilar Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Oncology Biosimilar Production from 2014-2020
4.3.5.2 Middle East & Africa Oncology Biosimilar Consumption from 2014-2020
4.3.5.3 Middle East & Africa Oncology Biosimilar Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Oncology Biosimilar Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Oncology Biosimilar Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Oncology Biosimilar Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Oncology Biosimilar Participants Value ($) and Market Share (%) in 2019
5. Competitive Intelligence – Company Profiles
5.1 Hospira
5.1.1 Hospira Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Hospira Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Baxter
5.2.1 Baxter Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Baxter Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Mylan
5.3.1 Mylan Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Mylan Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Celltrion
5.4.1 Celltrion Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Celltrion Sales, Growth Rate and Global Market Share from 2014-2020
5.5 BioXpress Therapeutics
5.5.1 BioXpress Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 BioXpress Therapeutics Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Dr. Reddy's Laboratories
5.6.1 Dr. Reddy's Laboratories Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Dr. Reddy's Laboratories Sales, Growth Rate and Global Market Share from 2014-2020
5.7 F. Hoffmann-La Roche
5.7.1 F. Hoffmann-La Roche Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 F. Hoffmann-La Roche Sales, Growth Rate and Global Market Share from 2014-2020
5.8 AbbVie
5.8.1 AbbVie Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 AbbVie Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Boehringer Ingelheim
5.9.1 Boehringer Ingelheim Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Boehringer Ingelheim Sales, Growth Rate and Global Market Share from 2014-2020
5.10 Biogen
5.10.1 Biogen Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.10.2 Biogen Sales, Growth Rate and Global Market Share from 2014-2020
5.11 Biocon
5.11.1 Biocon Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.11.2 Biocon Sales, Growth Rate and Global Market Share from 2014-2020
5.12 Allergan
5.12.1 Allergan Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.12.2 Allergan Sales, Growth Rate and Global Market Share from 2014-2020
5.13 AstraZeneca
5.13.1 AstraZeneca Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.13.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2014-2020
5.14 Sandoz
5.14.1 Sandoz Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.14.2 Sandoz Sales, Growth Rate and Global Market Share from 2014-2020
5.15 Amgen
5.15.1 Amgen Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.15.2 Amgen Sales, Growth Rate and Global Market Share from 2014-2020
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of the Global Oncology Biosimilar Market from 2021-2026
7.1 Future Forecast of Global Oncology Biosimilar Market from 2021-2026 Segment by Region
7.2 Future Forecast of the Global Oncology Biosimilar Market from 2021-2026 Segment by Types
7.3 Future Forecast of the Global Oncology Biosimilar Market from 2021-2026 Segment by End-User/Applications
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
9 Disclaimer
Global Oncology Biosimilar Market Value ($) and Growth Rate of Oncology Biosimilar from 2014-2026
Global Oncology Biosimilar Production and Growth Rate Segment by Product Types from 2014-2026F
Global Oncology Biosimilar Consumption and Growth Rate Segment by End-User/Application from 2014-2026E
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global Oncology Biosimilar Production and Growth Rate Segment by Product Types from 2014-2020
Table Global Oncology Biosimilar Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure Protein of Oncology Biosimilar
Figure Hormones of Oncology Biosimilar
Figure Uucleic Acids of Oncology Biosimilar
Table Global Oncology Biosimilar Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global Oncology Biosimilar Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Application 1 of Oncology Biosimilar
Figure Application 2 of Oncology Biosimilar
Figure Application 3 of Oncology Biosimilar
Table Global Oncology Biosimilar Production Value ($) by Regions
Table Global Oncology Biosimilar Production Value Share by Regions
Table Global Oncology Biosimilar Production by Regions
Table Global Oncology Biosimilar Production Share by Regions
Table Global Oncology Biosimilar Consumption by Regions
Table Global Oncology Biosimilar Consumption Share by Regions
Figure North America Oncology Biosimilar Production and Growth Rate from 2014-2020
Figure North America Oncology Biosimilar Consumption and Growth Rate from 2014-2020
Table North America Oncology Biosimilar Import and Export from 2014-2020
Table North America Oncology Biosimilar Value ($) and Growth (%) by Type from 2019-2020
Table North America Oncology Biosimilar Value ($) and Growth (%) by Application from 2019-2020
Table North America Oncology Biosimilar Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America Oncology Biosimilar Participants Value ($) and Market Share (%) in 2019
Figure Europe Oncology Biosimilar Production and Growth Rate from 2014-2020
Figure Europe Oncology Biosimilar Consumption and Growth Rate from 2014-2020
Table Europe Oncology Biosimilar Import and Export from 2014-2020
Table Europe Oncology Biosimilar Value ($) and Growth (%) by Type from 2019-2020
Table Europe Oncology Biosimilar Value ($) and Growth (%) by Application from 2019-2020
Table Europe Oncology Biosimilar Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe Oncology Biosimilar Participants Value ($) and Market Share (%) in 2019
Figure Asia-Pacific Oncology Biosimilar Production and Growth Rate from 2014-2020
Figure Asia-Pacific Oncology Biosimilar Consumption and Growth Rate from 2014-2020
Table Asia-Pacific Oncology Biosimilar Import and Export from 2014-2020
Table Asia-Pacific Oncology Biosimilar Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific Oncology Biosimilar Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific Oncology Biosimilar Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific Oncology Biosimilar Participants Value ($) and Market Share (%) in 2019
Figure Latin America Oncology Biosimilar Production and Growth Rate from 2014-2020
Figure Latin America Oncology Biosimilar Consumption and Growth Rate from 2014-2020
Table Latin America Oncology Biosimilar Import and Export from 2014-2020
Table Latin America Oncology Biosimilar Value ($) and Growth (%) by Type from 2019-2020
Table Latin America Oncology Biosimilar Value ($) and Growth (%) by Application from 2019-2020
Table Latin America Oncology Biosimilar Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America Oncology Biosimilar Participants Value ($) and Market Share (%) in 2019
Figure Middle East & Africa Oncology Biosimilar Production and Growth Rate from 2014-2020
Figure Middle East & Africa Oncology Biosimilar Consumption and Growth Rate from 2014-2020
Table Middle East & Africa Oncology Biosimilar Import and Export from 2014-2020
Table Middle East & Africa Oncology Biosimilar Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa Oncology Biosimilar Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa Oncology Biosimilar Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa Oncology Biosimilar Participants Value ($) and Market Share (%) in 2019
Table Hospira Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Hospira Sales and Growth Rate from 2014-2020
Figure Hospira Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Baxter Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Baxter Sales and Growth Rate from 2014-2020
Figure Baxter Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Mylan Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Mylan Sales and Growth Rate from 2014-2020
Figure Mylan Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Celltrion Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Celltrion Sales and Growth Rate from 2014-2020
Figure Celltrion Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table BioXpress Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure BioXpress Therapeutics Sales and Growth Rate from 2014-2020
Figure BioXpress Therapeutics Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Dr. Reddy's Laboratories Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Dr. Reddy's Laboratories Sales and Growth Rate from 2014-2020
Figure Dr. Reddy's Laboratories Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table F. Hoffmann-La Roche Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure F. Hoffmann-La Roche Sales and Growth Rate from 2014-2020
Figure F. Hoffmann-La Roche Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table AbbVie Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure AbbVie Sales and Growth Rate from 2014-2020
Figure AbbVie Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Boehringer Ingelheim Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Boehringer Ingelheim Sales and Growth Rate from 2014-2020
Figure Boehringer Ingelheim Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Biogen Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Biogen Sales and Growth Rate from 2014-2020
Figure Biogen Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Biocon Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Biocon Sales and Growth Rate from 2014-2020
Figure Biocon Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Allergan Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Allergan Sales and Growth Rate from 2014-2020
Figure Allergan Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table AstraZeneca Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure AstraZeneca Sales and Growth Rate from 2014-2020
Figure AstraZeneca Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Sandoz Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Sandoz Sales and Growth Rate from 2014-2020
Figure Sandoz Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Amgen Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Amgen Sales and Growth Rate from 2014-2020
Figure Amgen Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global Oncology Biosimilar Value ($) and Growth Rate Forecast by Regions (2021-2026)
Table Global Oncology Biosimilar Production and Growth Rate Forecast by Regions (2021-2026)
Table Global Oncology Biosimilar Consumption and Growth Rate Forecast by Regions (2021-2026)
Table Global Oncology Biosimilar Production and Growth Rate Forecast by Types (2021-2026)
Table Global Oncology Biosimilar Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...